MIF promoter polymorphisms are associated with epiretinal membrane but not retinal detachment with PVR in an american population.
作者信息
Cebulla Colleen M, Stevenson William, Van Law Heather, Heisler-Taylor Tyler, Hamadmad Sumaya, Shah Mohd Hussain, Kim Bongsu, Davidorf Frederick H, Ohr Matthew, Wells Michael, Yanoga Fatoumata, Chang Susie, Terrell William, Miller Daniel M, Klisovic Dino, Allen John B, Shah Niraj, Geraymovych Elena, Tarabishy Ahmad B, Kondapalli Srinivas S, Brewington Beatrice Y, Inman Andrea, Williams Demarcus, Kusibati Rania, Mathias Jay, Vedat Yildiz, Fernandez Soledad, Wisely C Ellis, Pilarski Robert, Abdel-Rahman Mohamed H
机构信息
The Ohio State University Department of Ophthalmology and Visual Science, Havener Eye Institute, 915 Olentangy River Road, Columbus, OH, 43212, USA.
The Ohio State University Department of Ophthalmology and Visual Science, Havener Eye Institute, 915 Olentangy River Road, Columbus, OH, 43212, USA.
出版信息
Exp Eye Res. 2019 Aug;185:107667. doi: 10.1016/j.exer.2019.05.007. Epub 2019 May 17.
Abstract
摘要
相似文献
1
MIF promoter polymorphisms are associated with epiretinal membrane but not retinal detachment with PVR in an american population.
Exp Eye Res. 2019 Aug;185:107667. doi: 10.1016/j.exer.2019.05.007. Epub 2019 May 17.
2
P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
Commun Biol. 2019 May 3;2:162. doi: 10.1038/s42003-019-0406-6. eCollection 2019.
3
Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):3112-7. doi: 10.1167/iovs.15-17791.
4
Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
Acta Diabetol. 2017 Apr;54(4):383-392. doi: 10.1007/s00592-016-0956-8. Epub 2017 Jan 9.
5
Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study.
Acta Ophthalmol Scand. 2006 Jun;84(3):309-13. doi: 10.1111/j.1600-0420.2005.00600.x.
6
ASSOCIATION STUDY BETWEEN POLYMORPHISMS OF THE p53 AND LYMPHOTOXIN ALPHA (LTA) GENES AND THE RISK OF PROLIFERATIVE VITREORETINOPATHY/RETINAL DETACHMENT IN A MEXICAN POPULATION.
Retina. 2018 Jan;38(1):187-191. doi: 10.1097/IAE.0000000000001508.
7
Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Am J Ophthalmol. 1999 Dec;128(6):763-5. doi: 10.1016/s0002-9394(99)00368-2.
8
Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
Biomed Pharmacother. 2019 Mar;111:548-554. doi: 10.1016/j.biopha.2018.12.044. Epub 2018 Dec 28.
9
Association between STR -794 CATT5-8 and SNP -173 G/C polymorphisms in the MIF gene and Lepromatous Leprosy in Mestizo patients of western Mexico.
Hum Immunol. 2016 Oct;77(10):985-989. doi: 10.1016/j.humimm.2016.07.006. Epub 2016 Jul 15.
引用本文的文献
1
Ibudilast Protects Retinal Bipolar Cells From Excitotoxic Retinal Damage and Activates the mTOR Pathway.
Glia. 2025 May;73(5):905-927. doi: 10.1002/glia.24657. Epub 2025 Feb 6.
2
The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy.
Front Immunol. 2019 Dec 4;10:2752. doi: 10.3389/fimmu.2019.02752. eCollection 2019.
本文引用的文献
1
MIF Inhibitor ISO-1 Protects Photoreceptors and Reduces Gliosis in Experimental Retinal Detachment.
Sci Rep. 2017 Oct 30;7(1):14336. doi: 10.1038/s41598-017-14298-9.
2
Macrophage migration inhibitory factor activates inflammatory responses of astrocytes through interaction with CD74 receptor.
Oncotarget. 2017 Jan 10;8(2):2719-2730. doi: 10.18632/oncotarget.13739.
3
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity suppresses microglia-mediated inflammatory responses.
Clin Exp Pharmacol Physiol. 2016 Nov;43(11):1134-1144. doi: 10.1111/1440-1681.12647.
4
Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences.
Prog Retin Eye Res. 2016 Mar;51:125-55. doi: 10.1016/j.preteyeres.2015.07.005. Epub 2015 Jul 21.
5
The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
PLoS One. 2013 Dec 9;8(12):e82283. doi: 10.1371/journal.pone.0082283. eCollection 2013.
6
The prevalence and risk factors of epiretinal membranes: the Melbourne Collaborative Cohort Study.
Retina. 2013 May;33(5):1026-34. doi: 10.1097/IAE.0b013e3182733f25.
7
A genetic case-control study confirms the implication of SMAD7 and TNF locus in the development of proliferative vitreoretinopathy.
Invest Ophthalmol Vis Sci. 2013 Mar 5;54(3):1665-78. doi: 10.1167/iovs.12-10931.
8
The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project.
Ophthalmology. 2013 Mar;120(3):623-628. doi: 10.1016/j.ophtha.2012.08.019. Epub 2012 Dec 1.
9
Pathology of epiretinal membrane, idiopathic macular hole, and vitreomacular traction syndrome.
Retina. 2012 Sep;32 Suppl 2:S194-8; discussion S198-9. doi: 10.1097/IAE.0b013e31825bc20a.
10
Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling.
Am J Ophthalmol. 2012 Aug;154(2):347-354.e2. doi: 10.1016/j.ajo.2012.02.004. Epub 2012 Apr 27.
Zotero 插件